Analytical Methods
54 entries.
-
Size-exclusion chromatography for peptides: secondary interactions, mobile phase design, and calibration limits
Size-exclusion chromatography is used to resolve peptide oligomers from monomer, but small peptides sit at the edge of its range. This post covers column selection, mobile phase, and calibration.
-
Carryover and ghost peaks in peptide HPLC: what blank injections reveal about adsorption, memory effects, and purity figures
Peptides adsorb to surfaces and re-emerge in later runs. This post reviews carryover mechanisms, blank-injection design, and how artifacts distort reported purity values.
-
Dynamic light scattering and sub-micron peptide assemblies: what the autocorrelation function can and cannot report
Dynamic light scattering detects peptide assemblies that HPLC and visual inspection miss. This post reviews intensity weighting, polydispersity, and interpretive limits.
-
Sterility Testing Under USP <71>: Membrane Filtration, Direct Inoculation, and Method Suitability for Peptide Solutions
A sterility test result is only as meaningful as its method suitability. How USP <71> compendial sterility testing is structured, and why peptide matrices complicate it.
-
Column selection for peptide RP-HPLC: pore size, particle architecture, and stationary phase chemistry
Peptide purity values depend on the column as much as the gradient. How pore size, superficially porous particles, and bonded phase chemistry shape peptide separations.
-
MALDI-TOF mass spectrometry for synthetic peptides: matrix selection, ionization behavior and limits
MALDI-TOF offers rapid intact-mass confirmation of synthetic peptides. This post reviews matrix choice, ion suppression, calibration and what a spectrum can and cannot establish.
-
Counting the counterions: ion chromatography and 19F NMR for the salt fraction of a synthetic peptide
Counterion content can account for a large share of a lyophilized peptide's mass. This post reviews ion chromatography and 19F NMR methods and their interpretive limits.
-
Amorphous or crystalline? X-ray powder diffraction and the solid-state character of lyophilized peptides
Lyophilized peptides are usually amorphous solids. This post reviews what X-ray powder diffraction can and cannot show about solid-state form and stability.
-
Bacterial endotoxin testing of peptide preparations: LAL interference, recovery, and what a pass result establishes
Endotoxin assays based on Limulus lysate are sensitive to peptide chemistry. This post reviews interference mechanisms, spike recovery, and the scope of a reported result.
-
Stable isotope-labeled internal standards in peptide LC-MS quantitation: what isotopic purity and label choice determine
Stable isotope-labeled peptides serve as internal standards in LC-MS quantitation. This post covers label selection, isotopic purity, and cross-signal contributions.
-
Ion mobility spectrometry and peptide isomers: collision cross section as an orthogonal identity dimension
Ion mobility separates gas-phase peptide ions by size and shape, resolving isomers that share a mass. This post covers drift time, collision cross section, and what the added dimension can show.
-
Mass accuracy, resolving power, and ppm error: what 'matches the theoretical mass' actually establishes
A reported mass match is only as informative as the instrument's accuracy and resolving power. This post explains ppm error, calibration, and the limits of mass alone.
-
Sodium and potassium adducts in electrospray spectra: reading the satellite peaks
Satellite peaks beside a peptide's main ion are often salt adducts, not impurities. This post explains how they form, how to recognize them, and what they imply.
-
b and y ions: how MS/MS fragmentation confirms a synthetic peptide sequence
An intact mass shows composition, not order. This post explains how collision-induced fragmentation produces b and y ion ladders and what they can and cannot establish.
-
Ellman's reagent and free thiol quantitation: what a cysteine count tells you about a peptide's disulfide status
Ellman's assay measures free sulfhydryl groups colorimetrically. This post reviews the chemistry, its limits, and how thiol data complements LC-MS.
-
Monoisotopic versus average mass: reading a peptide mass spectrum without fooling yourself
Why a peptide's observed mass depends on isotope envelopes and charge states, and how monoisotopic and average masses are matched to a theoretical value.
-
TFA versus formic acid in peptide LC-MS: ion pairing, signal suppression, and why one method may not serve both detectors
Mobile phase acid choice shapes both peak shape and mass spectrometric sensitivity. This post reviews ion pairing, signal suppression, and method trade-offs.
-
HILIC for polar peptides: retention logic where reversed-phase falls short
Hydrophilic interaction chromatography retains the small, polar, highly charged peptides that elute near the void in reversed-phase. A look at the mechanism, method variables, and COA implications.
-
Peak purity in peptide HPLC: the limits of spectral homogeneity
A diode-array peak purity pass is routinely read as proof that one chromatographic peak is one compound. For peptides, the chromophore makes it a weak one.
-
Lot sampling and retains: what a CoA result is representative of
A certificate of analysis reports a measurement on a sample, not on a vial. What connects the two is a sampling plan — and that plan is rarely stated.
-
System suitability testing: what the injections before your sample are meant to prove
A purity figure is only as good as the instrument that made it. What resolution, tailing, and injection-repeatability checks establish — and what they cannot.
-
Universal detection for peptides without a chromophore: charged aerosol detection and ELSD against UV
Many synthetic peptides absorb poorly above 250 nm. How CAD and ELSD respond by mass rather than absorbance, and what that changes on a purity chromatogram.
-
Quantitative NMR for synthetic peptides: an absolute assay that does not require a matching reference standard
qNMR ties peptide content to a certified internal standard through proton count alone. What the technique measures, where it outperforms AAA, and its limits.
-
Edman degradation: the sequence question that intact mass cannot close
Intact mass confirms composition, not order. What stepwise N-terminal sequencing still establishes about a synthetic peptide, and where the chemistry runs out.
-
Reference standards in peptide analysis: what the purity number is measured against
Every purity and content figure on a peptide COA is a comparison. The material on the other side of that comparison is the reference standard, and its qualification sets the ceiling on what the result can mean.
-
Ion-exchange chromatography for peptide charge variants: what RP-HPLC misses
Reversed-phase HPLC separates by hydrophobicity, so charge variants often co-elute with the main peak. Ion-exchange chromatography resolves them by net charge.
-
Sub-visible particulate matter in reconstituted peptide solutions
A solution that looks clear can still carry tens of thousands of particles per container. What light obscuration counts, what it misses, and why peptides complicate it.
-
Capillary electrophoresis as an orthogonal purity method for synthetic peptides
RP-HPLC separates peptides by hydrophobicity; capillary electrophoresis by charge-to-size ratio. Where the two disagree is where the information sits.
-
Circular dichroism and peptide higher-order structure: what a CD spectrum can and cannot settle
CD reports backbone conformation, not sequence. What the far-UV spectrum of a synthetic peptide actually establishes, and the ways it is routinely over-read.
-
UV quantitation of peptides: what A280 measures, and what it quietly assumes
UV absorbance is the fastest way to estimate peptide concentration. Its accuracy hinges on extinction coefficients, chromophore content, and matrix effects.
-
Amino acid analysis: the reference method that anchors peptide content to an absolute scale
HPLC purity is a relative measurement. Amino acid analysis is the absolute one. How hydrolysis, derivatization, and internal standards produce peptide content.
-
Peptide mapping and enzymatic digestion: localizing the modifications intact mass can't place
Intact mass shows that a modification happened, not where. How peptide mapping and LC-MS/MS localize oxidation, deamidation, and sequence errors to the residue.
-
Residual moisture in lyophilized peptides: what a Karl Fischer number actually measures
Water content is the least-read number on a peptide CoA. What Karl Fischer titration measures, how it differs from loss on drying, and why the value moves.
-
Forced degradation studies: how a peptide purity method proves it can actually see degradation
A purity assay is only meaningful if it detects the degradants that form. How stress testing under acid, base, oxidation, heat, and light validates peptide methods.
-
Elemental impurities in synthetic peptides: what ICH Q3D covers and why HPLC cannot see it
Chromatographic purity says nothing about trace metals. Where elemental impurities enter synthetic peptides, and how ICP-MS characterizes them.
-
Where synthetic peptide impurities come from: deletion, truncation, and side-chain artifacts in SPPS
Most impurities in a synthetic peptide are created during synthesis, not during storage. A look at deletion sequences, truncations, and side-chain artifacts.
-
Peptide counterions: what TFA and acetate salt forms mean for research material
Synthetic peptides are isolated as salts. Why trifluoroacetate dominates RP-HPLC purification, how acetate exchange works, and what counterion data mean.
-
Why two labs report different purity for the same peptide lot: RP-HPLC method variables
Two labs can report different purity figures for the same peptide lot. The RP-HPLC variables behind that gap: column chemistry, gradient slope, wavelength.
-
Endotoxin testing for research peptides: what LAL assays measure and what an EU/mg value means
Endotoxin is invisible to HPLC and mass spectrometry, so a 99% pure peptide can still carry a significant endotoxin burden. This post covers what the LAL assay detects and how to read an EU/mg figure on a certificate of analysis.
-
Peptide content vs chromatographic purity: why a 99% COA does not tell you how much peptide is in the vial
Chromatographic purity and peptide content measure different things. A lyophilate can be 99% pure by HPLC and still be 20% counterion and water by mass. This post covers the distinction and how each value is determined.
-
How mass spectrometry verifies peptide identity: MALDI-TOF vs ESI-MS
Purity and identity are separate questions, and chromatography only answers the first. This post covers how MALDI-TOF and ESI-MS establish that a peptide is the molecule it claims to be, and how to read the mass data on a certificate of analysis.
-
Semaglutide COA: What to look for in a certificate of analysis
A certificate of analysis for research-grade semaglutide should report mass verification, HPLC purity, water content, and endotoxin. Here's what each value means and how to spot a legitimate lab report.
-
What is Mazdutide? An Oxyntomodulin-Derived Dual Agonist
Mazdutide (development codes IBI362 and LY3305677) is a synthetic dual-receptor research peptide engineered from the oxyntomodulin backbone — the natural human peptide that endogenously engages both the GLP-1 receptor…
-
Lyophilization Chemistry: Why Research Peptides Come as Powder
Open any research peptide vial from any vendor and the contents look the same: a thin layer of white-to-off-white powder or a small puck of friable solid at the bottom of the vial. That puck is the result of…
-
Reading a Tirzepatide CoA: What Each Value Means
A Certificate of Analysis is the only document that connects a vial of lyophilized white powder to a defined molecular identity. For a 39-amino-acid lipidated peptide like tirzepatide, the CoA carries unusual weight:…
-
Thymosin Alpha-1: Immune Modulation Research
Thymosin Alpha-1 is one of the most-studied immune-modulating peptides in the published literature.
-
Understanding Peptide Purity: What 99% Actually Means
Almost every research peptide certificate of analysis (CoA) you'll pick up displays a purity figure — and that figure is almost always 99% or higher. On its face, this looks like a settled question: a vial is either pure or it isn't.
-
How to Verify a Peptide Lot in 90 Seconds
You have a vial in your hand. The label says BPC-157, 10 mg, with a lot number printed under the barcode.
-
Peptide Research Glossary: A Beginner’s Reference to the Terminology
The vocabulary of peptide research is its own dialect. A vial label, a Certificate of Analysis, and a published animal-research paper all assume the reader knows the basics: what a peptide actually is, what HPLC measures, what \"lyophilized\" means, what \"RUO\" stands for.
-
Why Third-Party CoAs Matter: An Industry-Standards Explainer for Research Peptide Buyers
A Certificate of Analysis (CoA) is the analytical record that a research-peptide vendor presents to attest to the identity and purity of a specific manufacturing lot.
-
Reconstitution Math: Calculating Concentration from a mg-per-Vial Lyophilized Peptide
A lyophilized research peptide arrives as a powder labeled with a gross mass — typically 5 mg, 10 mg, or higher. To use the compound in any research application, the powder must be dissolved in solvent, and the resulting solution must have a known, calculable concentration.
-
Lyophilized vs. Reconstituted Peptides: A Storage Protocol Guide
The lyophilized form of a research peptide is dramatically more stable than the reconstituted form — by orders of magnitude, in most cases. A properly stored lyophilized peptide maintains high...
-
How to Read a Peptide Certificate of Analysis (CoA): A Practical Guide for Researchers
A peptide Certificate of Analysis is the single document that distinguishes a reproducible research input from a black box. The CoA is the vendor's claim about what is actually in the vial,...
-
Understanding Certificates of Analysis (COAs): Why They Matter
Learn how to read and evaluate a Certificate of Analysis (COA), why third-party testing matters, and what to look for when sourcing research peptides.